Apyx Medical
(NASDAQ) APYX
Apyx Medical Financials at a Glance
Market Cap
$167.91M
Revenue (TTM)
$55.90M
Net Income (TTM)
-$9.17M
EPS (TTM)
-$0.22
P/E Ratio
-18.19
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$4.02
Volume
66,113.896
Open
$3.95
Price
$4.02
Volume
66,113.896
Open
$3.95
Previous Close
$4.01
Daily Range
$3.95 - $4.08
52-Week Range
$1.59 - $5.08
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
0.95 (Low)
Price
$4.02
Volume
66,113.896
Open
$3.95
Previous Close
$4.01
Daily Range
$3.95 - $4.08
52-Week Range
$1.59 - $5.08
Estimated Earnings Date
Aug 6, 2026
APYX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Apyx Medical
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
205
CEO
Charles D. Goodwin, II
Website
apyxmedical.comHeadquarters
Clearwater, FL 33760-4004, US
APYX Financials
Key Financial Metrics (TTM)
Gross Margin
32.27%
Operating Margin
-7.70%
Net Income Margin
-16.40%
Return on Equity
-90.62%
Return on Capital
-11.96%
Return on Assets
-14.55%
Earnings Yield
-5.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$167.91M
Shares Outstanding
41.87M
Volume
66.11K
Avg. Volume
175.99K
Financials (TTM)
Gross Profit
$18.04M
Operating Income
-$4.31M
EBITDA
-$2.44M
Operating Cash Flow
-$7.87M
Capital Expenditure
-$1.12M
Free Cash Flow
-$8.99M
Cash & ST Invst.
$31.14M
Total Debt
$39.46M
Apyx Medical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$12.49M
+32.4%
Gross Profit
$4.67M
-17.5%
Gross Margin
37.41%
N/A
Market Cap
$167.91M
N/A
Market Cap/Employee
$819.10K
N/A
Employees
205
N/A
Net Income
-$2.11M
+49.2%
EBITDA
-$429.00K
+83.6%
Quarterly Fundamentals
Total Cash
$31.14M
+0.4%
Total Debt
$39.46M
+1.4%
Accounts Receivable
$12.76M
+9.5%
Inventory
$9.54M
+24.1%
Long Term Debt
$39.02M
+1.2%
Short Term Debt
$441.00K
+17.9%
Return on Assets
-14.55%
N/A
Return on Invested Capital
-8.04%
N/A
Free Cash Flow
-$632.00K
+16.5%
Operating Cash Flow
-$572.00K
+18.5%